Qualis Innovations, Inc. (QLIS) Stock Analysis
DELISTED 2025
What happened to Qualis Innovations, Inc. (QLIS) stock?
Qualis Innovations, Inc. (QLIS) no longer trades on public markets. It was delisted in January 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2025
- Last recorded price (historical):
- $0.2667 (last quote on record before the January 2025 delisting; historical, not a current quote)
Market cap $5.45M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Qualis Innovations, Inc. (QLIS). Qualis Innovations, Inc. is a healthcare company focused on developing and distributing pain management solutions. Their lead product, SOLACE, is a non-invasive medical device designed to reduce pain using electromagnetic induction.
Last analyzed: Mar 16, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Qualis Innovations, Inc. (QLIS) Healthcare & Pipeline Overview
QLIS OTC Market Information
QLIS trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy QLIS shares?
No. QLIS stopped trading on public markets in January 2025, so the shares are not available through a broker. Anything you see quoted for QLIS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before QLIS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Qualis Innovations, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.